Watching CRISPR Therapeutics; Shares Move Higher, Traders Circulate Unconfirmed Rumor From M&A Blog Suggesting The Company Has Received A Takeover Approach From A Large U.S.- Listed Biotech Company
Author: Benzinga Newsdesk | November 17, 2025 10:59am